Registered Trials
-
NCT04783311
Phase 1/2Republic of Korea
Total Enrollment: 280
Official Trial Registration:
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.